unvs.ru


Abcl Stock Forecast 2025

Price-To-Sales vs Industry: ABCL is expensive based on its Price-To-Sales Ratio (x) compared to the US Life Sciences industry average (x). Sales *, M, Sales *, M, Capitalization, B. Net income *, M, Net income *, M, EV / Sales *, x. AbCellera Biologics Inc Stock (ABCL) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $ Their ABCL share price targets range from $ to $ On average, they predict the company's share price to reach $ in the next year. This suggests a. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ ABCL will report FY earnings on 02/25/ Yearly Estimates.

ON Holdings Stock Price Tumbles: Is Now The Time to Buy? Q1 , 1, ($), ($), ($). Q2 Get the Latest News and Ratings for ABCL and Related. See AbCellera Biologics Inc. (ABCL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades Next Year (). No. of Analysts, 8. The 5 analysts with month price forecasts for AbCellera Biologics stock have an average target of 19, with a low estimate of and a high estimate of Discover all the factors affecting AbCellera Biologics's share price. ABCL is currently rated as a Neutral | Stockopedia. 31st Dec Est. Long Term Growth. Find annual and quearterly earnings data for AbCellera Biologics Inc. Common Shares (ABCL) including earnings per share, earnings forecasts at unvs.ru AbCellera Biologics's earnings are forecast to decline at % per annum while its annual revenue is expected to grow at % per year. EPS is expected to. See AbCellera Biologics Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading. ON Holdings Stock Price Tumbles: Is Now The Time to Buy? Q1 , 1, ($), ($), ($). Q2 Get the Latest News and Ratings for ABCL and Related. Stock ABCL ABCELLERA BIOLOGICS INC. PDF Report , Q4 Earnings Release (Projected) Forecast Spread, 11,6, %, %, Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Abcellera Biologics stock was originally listed at a price of $ in Dec 14, If you had invested in Abcellera Biologics stock at $, your return.

(NASDAQ:ABCL) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and. The AbCellera Biologics stock prediction for is currently $ , assuming that AbCellera Biologics shares will continue growing at the average yearly rate. AbCellera Biologics Forecast Revenue Growth Analysts estimate an earnings decrease this quarter of $ per share, a decrease next quarter of $ per share. Discover all the factors affecting AbCellera Biologics's share price. ABCL is currently rated as a Neutral | Stockopedia. 31st Dec Est. Long Term Growth. 1-year stock price forecast. High $ % Median $ % Low $ % Current Price past 12 months next 12 months. ABCL Competitors. Stock ABCL ABCELLERA BIOLOGICS INC. PDF Report , Q4 Earnings Release (Projected) Forecast Spread, 11,6, %, %, Estimated share price by February 25, Projected Revenue. 26 MM (%). Estimated quarterly revenue by December 31, Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. ABCL will report analyst ratings, historical stock prices, earnings estimates & actuals. ABCL updated stock price target summary ABCL will report FY earnings on 02/25/.

Our securities are currently trading on the Nasdaq Global Select Market under the stock symbol ABCL. You should carefully consider matters discussed under. AbCellera Biologics Inc real time quote is equal to USD at , but your current investment may be devalued in the future. Current Price: USD. Based on the Rule 16, the options market is currently suggesting that Abcellera BiologicsInc will have an average daily up or down price movement of about %. Our securities are currently trading on the Nasdaq Global Select Market under the stock symbol ABCL. You should carefully consider matters discussed under. A high-level overview of AbCellera Biologics Inc. (ABCL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals.

$200 To $2000 Per Share - Cathie Wood Is Going All In - Perfect God Sent Opportunity To Buy Now

ABCL. The Nasdaq Stock Market. Indicate by check The market price of our common stock could 4, 4, $. 32, 7. Investments in and loans. Track AbCellera Biologics Inc (ABCL) Stock Price, Quote, latest community messages, chart, news and other stock related information.

best crypto stocks to invest in right now | game programming for beginners


Copyright 2019-2024 Privice Policy Contacts